Welcome to our dedicated page for Covista SEC filings (Ticker: CVSA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Covista Inc. filings document current reports on operating results, academic performance, investor communications and strategic progress for its healthcare education portfolio. Recent Form 8-K records furnish quarterly results releases, enrollment metrics, revenue and earnings measures, fiscal guidance, share repurchase activity, debt refinancing references and institutional updates for Chamberlain and Walden.
The company's Regulation FD disclosures also include investor newsletters describing milestones, partnerships, workforce-related initiatives and operational progress. Covista's filing record identifies public-company disclosure themes tied to results of operations, capital allocation, governance signatories, cautionary forward-looking statements and the company's current identity as a NYSE-listed healthcare educator.
Covista Inc. filed an initial Form 3 insider report for Amelia Manning, who serves as President, Chamberlain Univ. at the issuer. This filing establishes her status as a reporting officer under SEC rules. The data provided show no reported share transactions or holdings in this submission.
Covista Inc. filed an initial Form 3 insider report for Amelia Manning, who serves as President, Chamberlain Univ. at the issuer. This filing establishes her status as a reporting officer under SEC rules. The data provided show no reported share transactions or holdings in this submission.
Covista Inc. VP and Chief Accounting Officer Gangadharan Manjunath reported a routine tax-withholding transaction. On the vesting of previously awarded restricted stock units, 426 shares of common stock were used to satisfy tax withholding obligations at an indicated value of $127.85 per share. After this non-market disposition, he continues to hold 5,271 shares of Covista common stock directly.
Covista Inc. VP and Chief Accounting Officer Gangadharan Manjunath reported a routine tax-withholding transaction. On the vesting of previously awarded restricted stock units, 426 shares of common stock were used to satisfy tax withholding obligations at an indicated value of $127.85 per share. After this non-market disposition, he continues to hold 5,271 shares of Covista common stock directly.
Covista Inc.’s Chief Financial Officer Robert J. Phelan reported an open-market sale of 10,000 shares of common stock. The transaction took place on May 8, 2026 at a weighted average price of $126.2064 per share, in multiple trades between $125.00 and $128.09.
The sale was executed under a pre-established Rule 10b5-1 trading plan adopted on December 12, 2025, as required by Covista’s insider trading policy, which does not permit discretionary trades absent a hardship exception. The shares sold represent holdings above Covista’s Stock Ownership and Holding Requirements, and Phelan now directly owns 55,806 shares of Covista common stock.
Covista Inc.’s Chief Financial Officer Robert J. Phelan reported an open-market sale of 10,000 shares of common stock. The transaction took place on May 8, 2026 at a weighted average price of $126.2064 per share, in multiple trades between $125.00 and $128.09.
The sale was executed under a pre-established Rule 10b5-1 trading plan adopted on December 12, 2025, as required by Covista’s insider trading policy, which does not permit discretionary trades absent a hardship exception. The shares sold represent holdings above Covista’s Stock Ownership and Holding Requirements, and Phelan now directly owns 55,806 shares of Covista common stock.
Covista Inc. senior vice president and general counsel Douglas G. Beck sold 9,615 shares of common stock in an open-market transaction at a weighted average price of $127.0287 per share. The sale was executed on May 8, 2026 under a pre-established Rule 10b5-1 trading plan.
After this transaction, Beck directly holds 38,159 Covista common shares. The company’s policy allows no discretionary insider trades, so the sale formed part of pre-scheduled increments designed to reduce holdings above Covista’s stock ownership and holding requirements.
Covista Inc. senior vice president and general counsel Douglas G. Beck sold 9,615 shares of common stock in an open-market transaction at a weighted average price of $127.0287 per share. The sale was executed on May 8, 2026 under a pre-established Rule 10b5-1 trading plan.
After this transaction, Beck directly holds 38,159 Covista common shares. The company’s policy allows no discretionary insider trades, so the sale formed part of pre-scheduled increments designed to reduce holdings above Covista’s stock ownership and holding requirements.
Covista Inc. executive Karen Sue Cox, President of Chamberlain University, sold 2,000 shares of Covista common stock in an open-market transaction on May 8, 2026 at a weighted average price of $124.50 per share. The sale was executed under a pre-established Rule 10b5-1 trading plan adopted on December 15, 2025 and represents shares above Covista’s Stock Ownership and Holding Requirements. After this sale, Cox directly holds 31,596 Covista shares, and company policy permits only pre-scheduled plan trades absent a hardship exception.
Covista Inc. executive Karen Sue Cox, President of Chamberlain University, sold 2,000 shares of Covista common stock in an open-market transaction on May 8, 2026 at a weighted average price of $124.50 per share. The sale was executed under a pre-established Rule 10b5-1 trading plan adopted on December 15, 2025 and represents shares above Covista’s Stock Ownership and Holding Requirements. After this sale, Cox directly holds 31,596 Covista shares, and company policy permits only pre-scheduled plan trades absent a hardship exception.
Covista Inc. Chairman & CEO Stephen W. Beard reported an open-market sale of 15,874 shares of Covista common stock on May 8, 2026 at a weighted average price of $131.2529 per share. After this transaction, he directly holds 429,324 Covista shares.
The sale was carried out under a pre-established Rule 10b5-1 trading plan adopted on December 10, 2025 in line with Covista’s Insider Sales and Ownership Policy Addendum. Footnotes state that the shares sold represent a portion of holdings above Covista’s Stock Ownership and Holding Requirements and that all sales must occur under such pre-set plans absent a hardship exception.
The transaction was executed in multiple trades at prices ranging from $130.00 to $132.67 per share, with the reported price reflecting the weighted average sales price.
Covista Inc. Chairman & CEO Stephen W. Beard reported an open-market sale of 15,874 shares of Covista common stock on May 8, 2026 at a weighted average price of $131.2529 per share. After this transaction, he directly holds 429,324 Covista shares.
The sale was carried out under a pre-established Rule 10b5-1 trading plan adopted on December 10, 2025 in line with Covista’s Insider Sales and Ownership Policy Addendum. Footnotes state that the shares sold represent a portion of holdings above Covista’s Stock Ownership and Holding Requirements and that all sales must occur under such pre-set plans absent a hardship exception.
The transaction was executed in multiple trades at prices ranging from $130.00 to $132.67 per share, with the reported price reflecting the weighted average sales price.
Covista Inc filed a Form 144 reporting a proposed sale of 15,874 shares of common stock. The shares were acquired as compensation — Stock Options on 09/08/2025 and the planned method is described as Compensation — Cashless exercise / same-day sale. The filing lists 34,030,887 shares with a date of 05/08/2026 and shows an aggregate figure of $2,122,830.02.
Covista Inc filed a Form 144 reporting a proposed sale of 15,874 shares of common stock. The shares were acquired as compensation — Stock Options on 09/08/2025 and the planned method is described as Compensation — Cashless exercise / same-day sale. The filing lists 34,030,887 shares with a date of 05/08/2026 and shows an aggregate figure of $2,122,830.02.
ATGE reports proposed sales of common shares via a Form 144/A amendment listing specific vesting and performance-related grants and the related dates. The filing itemizes individual lots: 4,829, 4,778, 840, 4,274, 726, and 327 shares tied to vesting or performance stock units on dates from 11/10/2024 through 11/13/2025.
The entries are described as restricted stock vesting under a registered plan or Performance Stock Units and are labeled with the reason Services Rendered. The filing is an amendment (144/A) and lists the broker as Morgan Stanley Smith Barney LLC.
ATGE reports proposed sales of common shares via a Form 144/A amendment listing specific vesting and performance-related grants and the related dates. The filing itemizes individual lots: 4,829, 4,778, 840, 4,274, 726, and 327 shares tied to vesting or performance stock units on dates from 11/10/2024 through 11/13/2025.
The entries are described as restricted stock vesting under a registered plan or Performance Stock Units and are labeled with the reason Services Rendered. The filing is an amendment (144/A) and lists the broker as Morgan Stanley Smith Barney LLC.